BRONCHIOLITIS - Nursing Case Study

Pathophysiology

• Primary mechanism: Viral infection, predominantly by the Respiratory Syncytial Virus (RSV), leads to inflammation and swelling of the bronchioles, causing airway obstruction. This results in increased mucus production and impairs normal airflow, particularly affecting infants and young children.

• Secondary mechanism: The inflammatory response causes epithelial cell necrosis and sloughing, leading to further narrowing of the airway lumen. This exacerbates airflow limitation and contributes to ventilation-perfusion mismatch, ultimately causing hypoxia.

• Key complication: Severe bronchiolitis can progress to respiratory distress due to significant airway obstruction and impaired gas exchange, necessitating supportive interventions such as supplemental oxygen or mechanical ventilation in critical cases.

Patient Profile

Demographics:

6-month-old male, infant

History:

• Key past medical history: Premature birth at 32 weeks, history of mild asthma

• Current medications: Albuterol inhaler as needed, multivitamin drops

• Allergies: No known drug allergies

Current Presentation:

• Chief complaint: Difficulty breathing and wheezing

• Key symptoms: Cough, nasal congestion, poor feeding, irritability, low-grade fever

• Vital signs: Temperature 38.1°C, heart rate 160 bpm, respiratory rate 62 breaths per minute, oxygen saturation 89% on room air

Section 1

Change in Patient Status:

As the clinical team continues to monitor the 6-month-old infant with bronchiolitis, there is a noticeable change in his respiratory status. Despite initial efforts to alleviate symptoms with an albuterol inhaler and supportive care, the infant's respiratory distress has intensified. His respiratory rate has increased to 72 breaths per minute, and his oxygen saturation has further declined to 86% on room air, indicating worsening hypoxia. The use of accessory muscles is now apparent, with notable intercostal and subcostal retractions. Additionally, the infant exhibits nasal flaring and grunting, suggestive of increased work of breathing.

In light of these developments, the care team must reassess the current management plan. The decision is made to initiate supplemental oxygen therapy via nasal cannula to improve oxygenation. However, concerns arise regarding the potential for impending respiratory failure, given the rapid deterioration and the infant's history of prematurity and mild asthma, which may predispose him to more severe respiratory complications.

The clinical team considers further diagnostic evaluations to assess the extent of respiratory compromise and to rule out secondary infections or complications such as bacterial pneumonia. A chest X-ray is ordered to evaluate lung fields and potential atelectasis, while continued monitoring of blood gas levels is essential to gauge the effectiveness of interventions and guide further treatment. This situation underscores the need for prompt clinical reasoning and decision-making to prevent further deterioration and ensure the infant receives appropriate escalated care as needed.

Section 2

New Diagnostic Results:

As the clinical team proceeds with the updated management plan, the results from the chest X-ray reveal bilateral patchy infiltrates, suggesting the presence of viral pneumonia, a common complication in infants with bronchiolitis. The imaging also indicates areas of atelectasis, particularly in the right lower lobe, which might be contributing to the infant's increased work of breathing and hypoxia. This finding necessitates a reassessment of the treatment strategy, as the presence of pneumonia could exacerbate the infant's respiratory distress.

In parallel, the initial blood gas analysis shows a pH of 7.31, indicating mild respiratory acidosis, with a partial pressure of carbon dioxide (PaCO2) at 55 mmHg and a partial pressure of oxygen (PaO2) at 60 mmHg. These values confirm the infant's inadequate ventilation and oxygenation. The infant's WBC count is slightly elevated at 13,000/mm³, raising the suspicion for a secondary bacterial infection, despite the viral etiology of bronchiolitis. This prompts the initiation of empirical antibiotic therapy to address potential bacterial superinfection while awaiting blood culture results.

The combination of these diagnostic findings leads the clinical team to escalate care. The infant's supplemental oxygen is increased, and a trial of continuous positive airway pressure (CPAP) is considered to support ventilation and reduce atelectasis. The team discusses the potential need for transfer to a pediatric intensive care unit for closer monitoring and advanced respiratory support. These steps are critical to managing the infant's deteriorating condition and preventing progression to respiratory failure.

Section 3

Change in Patient Status:

Following the implementation of CPAP, the infant initially shows signs of stabilization, with a slight improvement in oxygen saturation levels, now consistently in the range of 92-94%. However, over the next few hours, the infant becomes increasingly lethargic and exhibits a reduced level of consciousness, raising immediate concern among the healthcare team. Physical examination reveals a decrease in responsiveness to stimuli, with a Glasgow Coma Scale score dropping to 9. The infant's respiratory rate, previously elevated at 60 breaths per minute, has now decreased to 28 breaths per minute, suggesting impending respiratory failure.

Vital signs indicate a heart rate of 160 beats per minute, and blood pressure remains stable at 85/55 mmHg. Despite the increased oxygen delivery and CPAP support, repeat blood gas analysis shows a worsening acidosis, with a pH of 7.28, PaCO2 at 60 mmHg, and PaO2 at 55 mmHg. These findings suggest inadequate ventilation and the possibility that the infant is tiring due to the increased work of breathing. The team also notes a further increase in WBC count to 15,000/mm³, reinforcing the suspicion of a superimposed bacterial infection.

Given the deteriorating clinical picture, the decision is made to transfer the infant to the pediatric intensive care unit for potential intubation and mechanical ventilation. This escalation in care is necessary to manage the infant's respiratory compromise and to provide closer monitoring. The team also plans to adjust the antibiotic regimen based on potential pathogen coverage and to continue supportive care measures to address the evolving complications. The prompt recognition and response to the infant's change in status are critical to preventing further decline and optimizing outcomes.

Section 4

As the infant is transferred to the pediatric intensive care unit, the healthcare team initiates a comprehensive assessment to determine the full extent of the infant's condition and to guide further interventions. Upon arrival, a thorough physical examination is conducted, revealing the infant's skin is cool and mottled, with capillary refill extending to 4 seconds, indicating possible compromised perfusion. Auscultation of the lungs reveals diminished breath sounds bilaterally with scattered wheezes, and the infant continues to show minimal response to tactile stimulation.

The team orders a chest X-ray and further laboratory tests, including a complete blood count, blood cultures, and a metabolic panel. The chest X-ray reveals diffuse bilateral infiltrates, consistent with both viral bronchiolitis and potential secondary bacterial pneumonia. Blood cultures are pending, but the clinical picture increasingly points towards a superimposed bacterial infection contributing to the infant’s deterioration. The metabolic panel shows elevated lactate levels at 4.5 mmol/L, suggesting tissue hypoxia due to inadequate oxygenation and ventilation.

In response to these findings, the clinical team prioritizes the initiation of broad-spectrum antibiotics, opting for a combination of ceftriaxone and vancomycin to cover both common and atypical pathogens. The infant is intubated and placed on mechanical ventilation with settings adjusted to improve ventilation and oxygenation, aiming to correct the respiratory acidosis. Continuous monitoring is instituted to assess for potential complications such as ventilator-associated pneumonia or further hemodynamic instability. The team’s goal is to stabilize the infant’s respiratory status, while also addressing the underlying infection and monitoring for any signs of further deterioration. This proactive approach is crucial to prevent additional complications and to promote recovery.

Section 5

As the infant remains in the pediatric intensive care unit, the healthcare team closely monitors for any changes in condition. Over the next few hours, despite the initiation of antibiotics and mechanical ventilation, the infant shows signs of further hemodynamic instability. Vital signs reveal a heart rate of 185 beats per minute, respiratory rate of 40 breaths per minute on ventilatory support, blood pressure of 70/45 mmHg, and an oxygen saturation of 88% despite high settings on the ventilator. These findings suggest potential worsening of the infant’s condition.

Repeat laboratory tests are conducted to reassess the infant's status. The complete blood count shows an increased white blood cell count of 22,000/µL, indicating a heightened inflammatory response. The metabolic panel reveals persistent elevated lactate levels at 5.2 mmol/L, despite improved ventilation, raising concerns about ongoing tissue hypoxia and possible septic shock. Arterial blood gas analysis indicates a pH of 7.28, pCO2 of 60 mmHg, and HCO3- of 19 mmol/L, consistent with a mixed respiratory and metabolic acidosis.

In response to the escalating situation, the clinical team considers the potential development of septic shock as a complication of the suspected secondary bacterial pneumonia. Immediate adjustments are made to the management plan, including the initiation of vasoactive medications to support blood pressure and perfusion. Fluid resuscitation is carefully titrated to avoid fluid overload while attempting to optimize cardiac output. The team also considers the need for additional cultures and sensitivity testing to ensure appropriate antibiotic coverage. This comprehensive approach aims to stabilize the infant while addressing the complex interplay of respiratory, infectious, and hemodynamic challenges, necessitating continued vigilance and adaptability in the treatment strategy.